Process for Tracking Utilization of COVID-19 Therapeutics
Year Developed: 2021
Resource Type: Document.Primary Audience: Administrative Staff; C-Suite (CEO, CFO, CIO, COO, etc.)
Language(s): English
Sponsored by: NACHC
Developed by: Assistant Secretary for Preparedness and Response (See other resources developed by this organization).
Resource Summary: This resource discusses who should report on the use of federally purchased therapeutics, rules governing reporting, and the process of reporting.
Resource Topic: Operations, Clinical Issues, Health Information Technology (HIT)/Data
Resource Subtopic: COVID-19.
Keywords: Data Collection, Management, and Analytics.This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,625,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.